Government Initiatives Boost Growth In Prenatal And Newborn Genetic Testing Market: A Key Factor Shaping the Future of the Prenatal And Newborn Genetic Testing Market in 2025

What Are the Projections for the Size and Growth Rate of the Prenatal And Newborn Genetic Testing Market?
The prenatal and newborn genetic testing market has expanded rapidly in recent years. It will grow from $6.68 billion in 2024 to $7.61 billion in 2025, at a CAGR of 13.9%. This growth is attributed to improved non-invasive prenatal testing, the rising maternal age, government support and healthcare policies, and patient demand for early detection.

The prenatal and newborn genetic testing market is expected to reach $12.04 billion by 2029, at a CAGR of 12.1%. Growth is due to the expansion of genetic test panels, increasing maternal health awareness, updated prenatal and newborn screening guidelines, a growing focus on rare diseases, and ethical and regulatory considerations. Major trends include non-invasive prenatal testing (NIPT), whole-genome sequencing (WGS), artificial intelligence (AI) integration, preimplantation genetic testing (PGT), and direct-to-consumer genetic testing.

What Are the Main Catalysts for Growth in the Prenatal And Newborn Genetic Testing Market?
Government initiatives and support for prenatal testing and newborn genetic screening are set to contribute to the expansion of the prenatal and newborn genetic testing markets. Government initiatives are specific programs, policies, or actions taken at various levels to support the well-being of citizens. In the context of prenatal and newborn genetic testing, these initiatives help identify genetic conditions or abnormalities in fetuses during pregnancy or in newborns shortly after birth. For example, in June 2022, the Australian government committed $1.3 million per year to the New South Wales (NSW) newborn screening program. This funding allows free screening tests for severe combined immunodeficiency (SCID) and spinal muscular atrophy (SMA), benefiting around 100,000 newborns annually and potentially saving the lives of up to 13 babies diagnosed with these conditions. Thus, government support for prenatal and newborn genetic screening is fostering the growth of these markets.

Get Your Free Sample Now - Explore Exclusive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=13158&type=smp

Which Businesses Are at the Forefront of Prenatal And Newborn Genetic Testing Market Development?
Major companies operating in the prenatal and newborn genetic testing market report are F. Hoffmann-La Roche AG, Novartis AG, Sanofi S.A., Thermo Fisher Scientific Inc., Abbott Laboratories, Danaher Corporation, Siemens Healthineers AG, Becton, Dickinson and Company, Quest Diagnostic Incorporated, Agilent Technologies Inc., Grifols S.A., Terumo Corporation, Illumina Inc., PerkinElmer Genomics, Quidel Corporation, Bio-Rad Laboratories Inc., Qiagen NV, Werfen S.A., DiaSorin S.p.A, Nova Biomedical, BGI Group, Natera Inc., Trinity Biotech PLC, Meridian Bioscience Inc., Sekisui Diagnostics, Chembio Diagnostics, PTS Diagnostics, Ariosa Diagnostics Inc., AccuBioTech Co. Ltd., Sequenom Inc.

What Are the Latest Innovations in the Prenatal And Newborn Genetic Testing Market?
Leading companies in the prenatal and newborn genetic testing markets are prioritizing the development of innovative screening tests, such as noninvasive prenatal screening tests, to enhance accessibility and affordability, ensuring reliable services for customers. Noninvasive prenatal screening (NIPS) or noninvasive prenatal testing (NIPT) is an advanced and safe genetic testing method conducted during pregnancy to detect potential fetal chromosomal abnormalities. For example, in November 2022, Juno Diagnostics Inc., a US-based healthcare technology firm, introduced Juno Hazel, a noninvasive prenatal screening test that identifies chromosomal abnormalities and delivers clinical insights. The test employs a sample collection kit, eliminating the need for phlebotomy, thereby improving accessibility. The company intends to collaborate with physicians and genetic counselors to offer educational resources and personalized genetic counseling support.

How Is the Prenatal And Newborn Genetic Testing Market Segmented?
The prenatal and newborn genetic testing market covered in this report is segmented -

1) By Product Type: Consumables, Instruments
2) By Screening: Non-Invasive Prenatal Testing, Chronic Villus Sampling, Amniocentesis, Maternal Serum Screening, Other Screenings
3) By Disease: Down Syndrome, ket*onuria, Cystic Fibrosis, Sickle Cell Anemia
4) By End User: Hospital, Maternity And Specialty Clinics, Diagnostic Centers

Subsegments:
1) By Consumables: Reagents And Assays, Sample Collection Kits, Test Kits
2) By Instruments: Polymerase Chain Reaction (PCR) Machines, Sequencers, Microarray Analyzers

Pre-Book Your Report Now For A Swift Delivery:
https://www.thebusinessresearchcompany.com/report/prenatal-and-newborn-genetic-testing-global-market-report

Where Is the Prenatal And Newborn Genetic Testing Market Growth Most Prominent?
North America was the largest region in the prenatal and newborn genetic testing market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the prenatal and newborn genetic testing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

What Is Covered In The Prenatal And Newborn Genetic Testing Global Market Report?

- Market Size Analysis: Analyze the Prenatal And Newborn Genetic Testing Market size by key regions, countries, product types, and applications.
- Market Segmentation Analysis: Identify various subsegments within the Prenatal And Newborn Genetic Testing Market for effective categorization.
- Key Player Focus: Focus on key players to define their market value, share, and competitive landscape.
- Growth Trends Analysis: Examine individual growth trends and prospects in the Market.
- Market Contribution: Evaluate contributions of different segments to the overall Prenatal And Newborn Genetic Testing Market growth.
- Growth Drivers: Detail key factors influencing market growth, including opportunities and drivers.
- Industry Challenges: Analyze challenges and risks affecting the Prenatal And Newborn Genetic Testing Market.
- Competitive Developments: Analyze competitive developments, such as expansions, agreements, and new product launches in the market.

Unlock Exclusive Market Insights - Purchase Your Research Report Now!
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=13158

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.